By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has partnered with Integrated Diagnostics to develop multiplexed protein biomarker-based assays for detecting diseases in their early stages.

The firms plan to develop high-throughput automated workflows for sample preparation and liquid chromatography mass spectrometry analysis, with the goal of accelerating biomarker discoveries by enabling screening of several hundred biomarkers in a single assay.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.